breast cancer

by Sanjukta Mondal, Medical Xpress edited by Sadie Harley, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Alternative medicine use instead of traditional therapy was associated with much lower 5-year survival. Credit: Leeloo The First: www.pexels.com/photo/a-pink-ribbon-on-white-calendar-7805646/ The alternative medicine industry is expanding rapidly, fueled in large part by the surge of health-related content on […]

by Ludwig Cancer Research edited by Gaby Clark, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source DTCs that escape from T cell killing express an Nr3c1 activation program. Credit: Nature (2026). DOI: 10.1038/s41586-026-10222-2 Cancer spreads (metastasizes) when tumor cells shed from a primary solid tumor (for example, in the breast) and embed in other organs, such

February 27th, 2026Posted by Texas A&M University Dark sweet cherries contain anthocyanins, natural plant compounds studied by Texas A&M researchers for their potential role in slowing the spread of triple-negative breast cancer. (Credit: Nadya Pichkasova/Texas A&M) Share this Article Facebook Twitter Reddit Email You are free to share this article under the Attribution 4.0 International license.

by Ecole Polytechnique Federale de Lausanne edited by Sadie Harley, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Model of PXS-5505 in action. In the absence of CDH1 the deposition and sensing of matrix components via integrins compensates and controls key transcriptional mediators, LOX inhibition perturbs this signaling axis, resulting in signaling and cell

by Johns Hopkins University School of Medicine edited by Stephanie Baum, reviewed by Andrew Zinin  Editors’ notes  The GIST Add as preferred source SMOX is a key node for breast oncogenesis mediated by multiple pathogenic microbes and pharmacological inhibition of SMOX can serve as an intervention strategy for breast cancer patients harboring microbial dysbiosis. Credits: Drs. Deeptashree Nandi

by UT Southwestern Medical Center edited by Lisa Lock, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Breast cancers treated with estrogen-depriving therapy were examined using fluorescent markers to highlight cancer cells (green), immune cells (red), cells that are actively dividing (yellow), and DNA, which marks the nucleus of every cell (blue). Credit: UT Southwestern Medical

by QIMR Berghofer Medical Research Institute edited by Gaby Clark, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Proposed model for BRRIAR as a positive regulator of RIG-I activation in ER + breast tumor cells to promote IFN production and support an anti-tumor immune response. Credit: Molecular Cancer (2026). DOI: 10.1186/s12943-025-02510-8 QIMR Berghofer scientists have discovered a cancer-fighting

by Mike Peña, University of California – Santa Cruz edited by Gaby Clark, reviewed by Andrew Zinin  Editors’ notes  The GIST Add as preferred source The orange cells in this image show abnormalities that emerge due to an inflammatory molecule that also accumulates with aging in mice that have not undergone pregnancy. Credit: Sikandar Lab A new study

by University of Texas MD Anderson Cancer Center edited by Sadie Harley, reviewed by Andrew Zinin  Editors’ notes  The GIST Add as preferred source Credit: CC0 Public Domain Researchers at The University of Texas MD Anderson Cancer Center have identified a targetable driver of brain metastases in patients with aggressive inflammatory breast cancer. The study uncovers a novel